Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SELZER, Edgar")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 28

  • Page / 2
Export

Selection :

  • and

Targeted Therapies in Solid Tumours: Pinpointing the Tumour's Achilles HeelKORNEK, Gabriela; SELZER, Edgar.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 207-242, issn 1381-6128, 36 p.Article

The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancerSCHINDL, Monika; BIRNER, Peter; BACHTIARY, Barbara et al.Anticancer research. 2000, Vol 20, Num 6B, pp 4551-4555, issn 0250-7005Article

Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell linesCZEMBIREK, Cornelia; EDER-CZEMBIREK, Christina; EROVIC, Boban M et al.Oncology reports. 2005, Vol 14, Num 6, pp 1523-1526, issn 1021-335X, 4 p.Article

Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survivalBACHTIARY, Barbara; SELZER, Edgar; KNOCKE, Tomas-Hendrik et al.Cancer letters. 2002, Vol 179, Num 2, pp 197-203, issn 0304-3835Article

After Injection into the Striatum, in Vitro-Differentiated Microglia-and Bone Marrow-Derived Dendritic Cells Can Leave the Central Nervous System via the Blood StreamHOCHMEISTER, Sonja; ZEITELHOFER, Manuel; BAUER, Jan et al.The American journal of pathology. 2008, Vol 173, Num 6, pp 1669-1681, issn 0002-9440, 13 p.Article

The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockadeBIGENZAHN, Sinda; BLAHA, Peter; WEKERLE, Thomas et al.American journal of transplantation (Print). 2005, Vol 5, Num 6, pp 1237-1247, issn 1600-6135, 11 p.Article

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynxGLASER, Christoph M; MILLESI, Werner; KORNEK, Gabriela V et al.International journal of radiation oncology, biology, physics. 2001, Vol 50, Num 3, pp 705-715, issn 0360-3016Article

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neckKEIL, Felix; SELZER, Edgar; BURIAN, Martin et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 352-359, issn 0959-8049, 8 p.Article

Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis : Inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412AICHBERGER, Karl J; MAYERHOFER, Matthias; SILLABER, Christian et al.Blood. 2007, Vol 109, Num 7, pp 3031-3041, issn 0006-4971, 11 p.Article

Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML) : evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotidesAICHBERGER, Karl J; MAYERHOFER, Matthias; SELZER, Edgar et al.Blood. 2005, Vol 105, Num 8, pp 3303-3311, issn 0006-4971, 9 p.Article

Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neckSKODA, Christiane; EROVIC, Boban M; WACHEK, Volker et al.Oncology reports. 2008, Vol 19, Num 6, pp 1499-1503, issn 1021-335X, 5 p.Article

Mcl-1 is a novel therapeutic target for human sarcoma: Synergistic inhibition of human sarcoma xenotransplants by a combination of Mcl-1 antisense oligonucleotides with low-dose cyclophosphamideTHALLINGER, Christiane; WOLSCHEK, Markus F; MAIERHOFER, Helmut et al.Clinical cancer research. 2004, Vol 10, Num 12, pp 4185-4191, issn 1078-0432, 7 p., 1Article

Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcomaCHOTT, Andreas; GUENTHER, Philipp; HUEBNER, Angela et al.The American journal of surgical pathology. 2003, Vol 27, Num 7, pp 1013-1019, issn 0147-5185, 7 p.Article

Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: Regulation of expression and activation by interleukin-1 and tumor necrosis factor αREDLICH, Kurt; KIENER, Hans P; ZENZ, Peter et al.Arthritis and rheumatism. 2001, Vol 44, Num 2, pp 266-274, issn 0004-3591Article

Antiinflammatory Effects of Tumor Necrosis Factor on Hematopoietic Cells in a Murine Model of Erosive ArthritisBLÜML, Stephan; BINDER, Nikolaus B; BILBAN, Martin et al.Arthritis and rheumatism. 2010, Vol 62, Num 6, pp 1608-1619, issn 0004-3591, 12 p.Article

Low-level expression of proapoptotic bcl-2-lnteracting mediator in leukemic cells in patients with chronic myeloid leukemia : Role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compoundsAICHBERGER, Karl J; MAYERHOFER, Matthias; SILLABER, Christian et al.Cancer research (Baltimore). 2005, Vol 65, Num 20, pp 9436-9444, issn 0008-5472, 9 p.Article

Mc1-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation modelTHALLINGER, Christiane; WOLSCHEK, Markus F; JANSEN, Burkhard et al.Journal of investigative dermatology. 2003, Vol 120, Num 6, pp 1081-1086, issn 0022-202X, 6 p.Article

Impact of elective neck dissection on regional recurrence and survival in cN0 staged oral maxillary squamous cell carcinomaPOESCHL, Paul W; SEEMANN, Rudolf; CZEMBIREK, Cornelia et al.Oral oncology (1997). 2012, Vol 48, Num 2, pp 173-178, issn 1368-8375, 6 p.Article

Mcl-1,vascular endothelial growth factor-R2, and 14-3-3σ expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neckEROVIC, Boban M; PEIZMANN, Martina; GRASL, Matthäus Ch et al.Clinical cancer research. 2005, Vol 11, Num 24, pp 8632-8636, issn 1078-0432, 5 p., 1Article

Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabineKORNEK, Gabriela V; PÖTTER, Richard; SELZER, Edgar et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 3, pp 665-671, issn 0360-3016Article

CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHERRMANN, Harald; CERNY-REITERER, Sabine; SCHWARZINGER, Ilse et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 219-226, issn 0390-6078, 8 p.Article

Continuous thrombin infusion leads to a bleeding phenotype in sheepSILLER-MATULA, Jolanta M; MILLER, Ingrid; PLANCHON, Sébastien et al.Thrombosis research. 2012, Vol 130, Num 2, pp 226-236, issn 0049-3848, 11 p.Article

Validity of Sentinel Lymph Node (SLN) Detection Following Adjuvant Radiochemotherapy (RCT) in Head and Neck Squamous Cell Carcinoma (HNSCC)WAGNER, Arne; KERMER, Christian; ZETTINIG, Georg et al.Technology in cancer research & treatment (Print). 2007, Vol 6, Num 6, pp 655-660, issn 1533-0346, 6 p.Article

Combination of betulinic acid with cisplatin - different cytotoxic effects in two head and neck cancer cell linesEDER-CZEMBIREK, Christina; CZEMBIREK, Cornelia; EROVIC, Boban M et al.Oncology reports. 2005, Vol 14, Num 3, pp 667-671, issn 1021-335X, 5 p.Article

Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell deathSKVARA, Hans; THALLINGER, Christiane; WACHECK, Volker et al.Anticancer research. 2005, Vol 25, Num 4, pp 2697-2703, issn 0250-7005, 7 p.Article

  • Page / 2